Return to drugs

Micafungin

Лиофилизат By prescription

Antifungal drug of the echinocandins group

50/100 mg

Micafungin

Important

Micafungin should be used only after careful assessment of the expected benefit and existing risk of therapy in patients with impaired liver function, in the presence of clinical and laboratory evidence of haemolysis or haemolytic anaemia. With caution, under careful clinical supervision and monitoring of plasma concentrations, micafungin should be used concomitantly with sirolimus, nifedipine.

Indications

Adults (including the elderly) and adolescents ≥ 16 years of age:
- Treatment of invasive candidiasis;

- treatment of oesophageal candidiasis in patients requiring intravenous administration of antifungal agents;

- prophylaxis of candidiasis in patients after allogeneic hematopoietic stem cell transplantation or in patients suspected of neutropenia (neutrophil count < 500/μL) for 10 days or more.

Children (including neonates) and adolescents < 16 years of age:
- Treatment of invasive candidiasis;

- prophylaxis of candidiasis in patients after allogeneic hematopoietic stem cell transplantation or in patients suspected of neutropenia (neutrophil count < 500/μL) for 10 days or more.

Contraindications

Hypersensitivity to or intolerance of micafungin, other echinocandins or any of the excipients.

Usage

It is administered intravenously in the form of infusion.

For the treatment of esophageal candidiasis — 150 mg/day.

For prophylaxis of candidiasis in patients after haematopoietic stem cell transplantation the dose is 50 mg/day.

Duration of use is established individually.

Download full instruction

Report undesirable reaction

If you have information about undesirable reaction after taking the drug

Hotline +7 (495) 984-28-47

Have questions? Contact Us

Drugs in the category Therapy

Has contraindications. Needs specialist overview.

Please read our privacy policy

The present personal data processing policy is drawn up in accordance with the requirements of the Federal Law of July 27, 2006. No. 152-FЗ “On Personal Data” and determines the procedure for processing personal data and measures to ensure the security of personal data of Mir-Pharm LLC (hereinafter referred to as the Operator).

The operator sets as his most important goal and condition for the implementation of his activities the respect for the rights and freedoms of man and citizen in the processing of his personal data, including the protection of the rights to privacy, personal and family confidentiality.

The Operator's policy regarding the processing of personal data (hereinafter - the Policy) applies to all information that the Operator can receive about visitors of the website https://mirpharm.ru.

The user can get any clarification on issues of interest regarding the processing of his personal data by contacting the Operator via e-mail info@mirpharm.ru.

The current version of the Policy is located in free access on the Internet at https://mirpharm.ru/policy.

This document will reflect any changes in the policy of processing personal data by the Operator. The policy is valid indefinitely until it is replaced with a new version.